BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qiu W, Chen R, Chen X, Zhang H, Song L, Cui W, Zhang J, Ye D, Zhang Y, Wang Z. Oridonin-loaded and GPC1-targeted gold nanoparticles for multimodal imaging and therapy in pancreatic cancer. Int J Nanomedicine 2018;13:6809-27. [PMID: 30425490 DOI: 10.2147/IJN.S177993] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang H, Cai R, Zhang Y, Chen Y, Gu B. Gold Nanoclusters as an Antibacterial Alternative Against Clostridium difficile. Int J Nanomedicine 2020;15:6401-8. [PMID: 32904597 DOI: 10.2147/IJN.S268758] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Shete MB, Patil TS, Deshpande AS, Saraogi G, Vasdev N, Deshpande M, Rajpoot K, Tekade RK. Current trends in theranostic nanomedicines. Journal of Drug Delivery Science and Technology 2022;71:103280. [DOI: 10.1016/j.jddst.2022.103280] [Reference Citation Analysis]
3 Tomşa AM, Răchişan AL, Aldea AA, Ciumărnean L. Perspectives of gold nanoparticles and their applications in pancreatic cancer (Review). Exp Ther Med 2021;21:258. [PMID: 33603865 DOI: 10.3892/etm.2021.9689] [Reference Citation Analysis]
4 Singh R. Nanotechnology based therapeutic application in cancer diagnosis and therapy. 3 Biotech 2019;9:415. [PMID: 31696020 DOI: 10.1007/s13205-019-1940-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
5 Furini S, Falciani C. Expression and Role of Heparan Sulfated Proteoglycans in Pancreatic Cancer. Front Oncol 2021;11:695858. [PMID: 34249755 DOI: 10.3389/fonc.2021.695858] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Gromisch C, Qadan M, Machado MA, Liu K, Colson Y, Grinstaff MW. Pancreatic Adenocarcinoma: Unconventional Approaches for an Unconventional Disease. Cancer Res 2020;80:3179-92. [PMID: 32220831 DOI: 10.1158/0008-5472.CAN-19-2731] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Calderan L, Malatesta M. Imaging techniques in nanomedical research. Eur J Histochem 2020;64. [PMID: 32613820 DOI: 10.4081/ejh.2020.3151] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Nedelcu A, Mocan T, Grapa C, Mocan L. Recent Advances in Nanoparticle-Mediated Diagnosis and the Treatment of Pancreatic Cancer. Int J Mol Sci 2021;22:8060. [PMID: 34360829 DOI: 10.3390/ijms22158060] [Reference Citation Analysis]
9 Yang Z, Wang D, Zhang C, Liu H, Hao M, Kan S, Liu D, Liu W. The Applications of Gold Nanoparticles in the Diagnosis and Treatment of Gastrointestinal Cancer. Front Oncol 2022;11:819329. [DOI: 10.3389/fonc.2021.819329] [Reference Citation Analysis]
10 Mio C, Bulotta S, Russo D, Damante G. Reading Cancer: Chromatin Readers as Druggable Targets for Cancer Treatment. Cancers (Basel) 2019;11:E61. [PMID: 30634442 DOI: 10.3390/cancers11010061] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
11 Qiu W, Wang Z, Chen R, Shi H, Ma Y, Zhou H, Li M, Li W, Chen H, Zhou H. Xiaoai Jiedu Recipe suppresses hepatocellular carcinogenesis through the miR-200b-3p /Notch1 axis. Cancer Manag Res 2020;12:11121-31. [PMID: 33173345 DOI: 10.2147/CMAR.S269991] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Gupta S, Tejavath KK. Nano Phytoceuticals: A Step Forward in Tracking Down Paths for Therapy Against Pancreatic Ductal Adenocarcinoma. J Clust Sci. [DOI: 10.1007/s10876-021-02213-2] [Reference Citation Analysis]
13 Jugniot N, Bam R, Meuillet EJ, Unger EC, Paulmurugan R. Current status of targeted microbubbles in diagnostic molecular imaging of pancreatic cancer. Bioeng Transl Med 2021;6:e10183. [PMID: 33532585 DOI: 10.1002/btm2.10183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Zhang Y, Wang S, Dai M, Nai J, Zhu L, Sheng H. Solubility and Bioavailability Enhancement of Oridonin: A Review. Molecules 2020;25:E332. [PMID: 31947574 DOI: 10.3390/molecules25020332] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
15 Qiu W, Zhang H, Chen X, Song L, Cui W, Ren S, Wang Y, Guo K, Li D, Chen R, Wang Z. A GPC1-targeted and gemcitabine-loaded biocompatible nanoplatform for pancreatic cancer multimodal imaging and therapy. Nanomedicine (Lond) 2019;14:2339-53. [PMID: 31414945 DOI: 10.2217/nnm-2019-0063] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
16 Tauseef A, Hisam F, Hussain T, Caruso A, Hussain K, Châtel A, Chénais B. Nanomicrobiology: Emerging Trends in Microbial Synthesis of Nanomaterials and Their Applications. J Clust Sci. [DOI: 10.1007/s10876-022-02256-z] [Reference Citation Analysis]
17 Orellana N, Palma S, Torres E, Cordero ML, Vio V, Ruso JM, Juárez J, Topete A, Araya E, Vasquez-Contreras R, Kogan MJ, Hassan N. Study of the interaction of folic acid-modified gold nanorods and fibrinogen through microfluidics: implications for protein adsorption, incorporation and viability of cancer cells. Nanoscale 2021;13:17807-21. [PMID: 34668502 DOI: 10.1039/d1nr03179a] [Reference Citation Analysis]
18 Ren S, Song L, Tian Y, Zhu L, Guo K, Zhang H, Wang Z. Emodin-Conjugated PEGylation of Fe3O4 Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer. Int J Nanomedicine 2021;16:7463-78. [PMID: 34785894 DOI: 10.2147/IJN.S335588] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Chen G, Luo J, Cai M, Qin L, Wang Y, Gao L, Huang P, Yu Y, Ding Y, Dong X, Yin X, Ni J. Investigation of Metal-Organic Framework-5 (MOF-5) as an Antitumor Drug Oridonin Sustained Release Carrier. Molecules 2019;24:E3369. [PMID: 31527488 DOI: 10.3390/molecules24183369] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 5.7] [Reference Citation Analysis]